Literature DB >> 24596369

Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer.

Takaaki Fujii1, Reina Yajima, Tomoko Hirakata, Takeshi Miyamoto, Tomomi Fujisawa, Soichi Tsutsumi, Yasuhiro Ynagita, Misa Iijima, Hiroyuki Kuwano.   

Abstract

BACKGROUND: The prognostic value of lymphovascular invasion (LVI) in patients with breast cancer is unclear. Lymphatic invasion may mainly represent the selective affinity of breast cancer cells for lymph nodes. This study was undertaken to evaluate the presence of vascular invasion that may reflect systemic disease as a predictor of disease recurrence in breast cancer, separate from lymphatic invasion of the primary tumor. PATIENTS AND METHODS: We retrospectively evaluated the cases of 263 consecutive female patients with primary breast cancer who underwent a radical breast operation. We examined the relationship between recurrence and the prognostic significance of clinico-pathological factors, particularly lymphatic (Iy) and vascular invasion (v).
RESULTS: The presence of lymphatic invasion and that of vascular invasion were significant in univariate analysis. The presence of vascular invasion was an independent prognostic factor, but lymphatic invasion lost its prognostic significance in multivariate analysis. Among the 91 patients in the ly-/v- group, 5 (5.5%) had disease recurrence, and among the 73 patients in the ly+/v- group, 5 (6.8%) had disease recurrence. On the other hand, among the 95 patients in the ly+/v+ group, 19 (20.0%) had a recurrence, and among the 3 patients in the ly-/v+ group, one had a recurrence. It is interesting to note that despite the presence of lymphatic invasion, the group without vascular invasion (ly+/v-) had a few patients with distant metastases, a result which is similar to that of the ly-/v- group.
CONCLUSION: The presence of vascular invasion, but not lymphatic invasion, could be an indicator of high biological aggressiveness and may be a valid prognostic factor for breast cancer.

Entities:  

Keywords:  Vascular invasion; breast cancer; lymphatic invasion; prognosis

Mesh:

Year:  2014        PMID: 24596369

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinoma.

Authors:  Xianlu Zhuo; Aoshuang Chang; Chuang Huang; Li Yang; Zhaolan Xiang; Yan Zhou
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.

Authors:  Shao-Qian Cui; Huan Wang
Journal:  Tumour Biol       Date:  2015-04-09

3.  Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.

Authors:  Takao Kato; Francesco Pezzella; Graham Steers; Leticia Campo; Russell D Leek; Helen Turley; Shingo Kameoka; Toshio Nishikawa; Adrian L Harris; Kevin C Gatter; Stephen Fox
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer.

Authors:  Tianfu Lai; Xiaofeng Chen; Zhiqi Yang; Ruibin Huang; Yuting Liao; Xiangguang Chen; Zhuozhi Dai
Journal:  Cancer Imaging       Date:  2022-10-22       Impact factor: 5.605

5.  High FUT3 expression is a marker of lower overall survival of breast cancer patients.

Authors:  Jessica Catarine Frutuoso do Nascimento; Eduardo Isidoro Carneiro Beltrão; Cíntia Renata Costa Rocha
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

Review 6.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

7.  Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy.

Authors:  Naveen Kumar; Masoom Raza; Seema Sehrawat
Journal:  Mol Cell Biochem       Date:  2021-07-29       Impact factor: 3.396

8.  Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.

Authors:  Hong Jun Kim; Min Jee Jo; Bo Ram Kim; Jung Lim Kim; Yoon A Jeong; Yoo Jin Na; Seong Hye Park; Suk-Young Lee; Dae-Hee Lee; Hye Seung Lee; Baek-Hui Kim; Sun Il Lee; Byung Wook Min; Young Do Yoo; Sang Cheul Oh
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study.

Authors:  Zhiying Shao; Shalini Chaudhri; Meng Guo; Longzhen Zhang; Daniel Rea
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

Review 10.  Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer.

Authors:  Jia-Mei Chen; Bo Luo; Ru Ma; Xi-Xi Luo; Yong-Shun Chen; Yan Li
Journal:  Diagnostics (Basel)       Date:  2021-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.